Previous Article | Next Article 
Journal of Virology, November 2001, p. 11079-11087, Vol. 75, No. 22
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.22.11079-11087.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Replication-Competent or Attenuated, Nonpropagating Vesicular
Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV)
Antigens Protect Mice against RSV Challenge
Jeffrey S.
Kahn,1,*
Anjeanette
Roberts,2
Carla
Weibel,1
Linda
Buonocore,2 and
John
K.
Rose2
Department of Pediatrics, Division of
Infectious Diseases,1 and Department of
Pathology,2 Yale University School of
Medicine, New Haven, Connecticut 06520
Received 29 May 2001/Accepted 16 August 2001
Foreign glycoproteins expressed in recombinant
vesicular stomatitis virus (VSV) can elicit specific and protective
immunity in the mouse model. We have previously demonstrated the
expression of respiratory syncytial virus (RSV) G (attachment) and F
(fusion) glycoprotein genes in recombinant VSV. In this
study, we demonstrate the expression of RSV F and G
glycoproteins in attenuated, nonpropagating VSVs which lack
the VSV G gene (VSV
G) and the incorporation of these RSV proteins
into recombinant virions. We also show that intranasal vaccination of
mice with nondefective VSV recombinants expressing RSV G (VSV-RSV G) or
RSV F (VSV-RSV F) elicited RSV-specific antibodies in serum (by
enzyme-linked immunosorbent assay [ELISA]) as well as neutralizing
antibodies to RSV and afford complete protection against RSV challenge.
In contrast, VSV
G-RSV F induced detectable serum antibodies to RSV
by ELISA, but no detectable neutralizing antibodies, yet it still
protected from RSV challenge. VSV
G-RSV G failed to induce any
detectable serum (by ELISA) or neutralizing antibodies and failed to
protect from RSV challenge. The attenuated, nonpropagating VSV
G-RSV
F is a particularly attractive candidate for a live attenuated
recombinant RSV vaccine.
*
Corresponding author. Mailing address: Department of
Pediatrics, Division of Infectious Diseases, LSOG 416, Yale University School of Medicine, P.O. Box 208064, New Haven, CT 06520-8064. Phone:
(203) 785-6778. Fax: (203) 785-6961. E-mail:
jeffrey.kahn{at}yale.edu.
Journal of Virology, November 2001, p. 11079-11087, Vol. 75, No. 22
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.22.11079-11087.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Xu, R., Nasar, F., Megati, S., Luckay, A., Lee, M., Udem, S. A., Eldridge, J. H., Egan, M. A., Emini, E., Clarke, D. K.
(2009). Prime-Boost Vaccination with Recombinant Mumps Virus and Recombinant Vesicular Stomatitis Virus Vectors Elicits an Enhanced Human Immunodeficiency Virus Type 1 Gag-Specific Cellular Immune Response in Rhesus Macaques. J. Virol.
83: 9813-9823
[Abstract]
[Full Text]
-
Mapletoft, J. W., Oumouna, M., Kovacs-Nolan, J., Latimer, L., Mutwiri, G., Babiuk, L. A., van Drunen Littel-van den Hurk, S.
(2008). Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection. J. Gen. Virol.
89: 250-260
[Abstract]
[Full Text]
-
Cooper, D., Wright, K. J., Calderon, P. C., Guo, M., Nasar, F., Johnson, J. E., Coleman, J. W., Lee, M., Kotash, C., Yurgelonis, I., Natuk, R. J., Hendry, R. M., Udem, S. A., Clarke, D. K.
(2008). Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice. J. Virol.
82: 207-219
[Abstract]
[Full Text]
-
Mok, H., Lee, S., Utley, T. J., Shepherd, B. E., Polosukhin, V. V., Collier, M. L., Davis, N. L., Johnston, R. E., Crowe, J. E. Jr.
(2007). Venezuelan Equine Encephalitis Virus Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton Rats. J. Virol.
81: 13710-13722
[Abstract]
[Full Text]
-
Brandsma, J. L., Shylankevich, M., Su, Y., Roberts, A., Rose, J. K., Zelterman, D., Buonocore, L.
(2007). Vesicular Stomatitis Virus-Based Therapeutic Vaccination Targeted to the E1, E2, E6, and E7 Proteins of Cottontail Rabbit Papillomavirus. J. Virol.
81: 5749-5758
[Abstract]
[Full Text]
-
Ramsburg, E. A., Publicover, J. M., Coppock, D., Rose, J. K.
(2007). Requirement for CD4 T Cell Help in Maintenance of Memory CD8 T Cell Responses Is Epitope Dependent. J. Immunol.
178: 6350-6358
[Abstract]
[Full Text]
-
Clarke, D. K., Nasar, F., Lee, M., Johnson, J. E., Wright, K., Calderon, P., Guo, M., Natuk, R., Cooper, D., Hendry, R. M., Udem, S. A.
(2007). Synergistic Attenuation of Vesicular Stomatitis Virus by Combination of Specific G Gene Truncations and N Gene Translocations. J. Virol.
81: 2056-2064
[Abstract]
[Full Text]
-
Simon, I. D., Publicover, J., Rose, J. K.
(2007). Replication and Propagation of Attenuated Vesicular Stomatitis Virus Vectors In Vivo: Vector Spread Correlates with Induction of Immune Responses and Persistence of Genomic RNA. J. Virol.
81: 2078-2082
[Abstract]
[Full Text]
-
Bukreyev, A., Skiadopoulos, M. H., Murphy, B. R., Collins, P. L.
(2006). Nonsegmented negative-strand viruses as vaccine vectors.. J. Virol.
80: 10293-10306
[Full Text]
-
Majid, A. M., Ezelle, H., Shah, S., Barber, G. N.
(2006). Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle. J. Virol.
80: 6993-7008
[Abstract]
[Full Text]
-
Publicover, J., Ramsburg, E., Rose, J. K.
(2005). A Single-Cycle Vaccine Vector Based on Vesicular Stomatitis Virus Can Induce Immune Responses Comparable to Those Generated by a Replication-Competent Vector. J. Virol.
79: 13231-13238
[Abstract]
[Full Text]
-
Leung, J., Esper, F., Weibel, C., Kahn, J. S.
(2005). Seroepidemiology of Human Metapneumovirus (hMPV) on the Basis of a Novel Enzyme-Linked Immunosorbent Assay Utilizing hMPV Fusion Protein Expressed in Recombinant Vesicular Stomatitis Virus. J. Clin. Microbiol.
43: 1213-1219
[Abstract]
[Full Text]
-
Publicover, J., Ramsburg, E., Rose, J. K.
(2004). Characterization of Nonpathogenic, Live, Viral Vaccine Vectors Inducing Potent Cellular Immune Responses. J. Virol.
78: 9317-9324
[Abstract]
[Full Text]
-
Obuchi, M., Fernandez, M., Barber, G. N.
(2003). Development of Recombinant Vesicular Stomatitis Viruses That Exploit Defects in Host Defense To Augment Specific Oncolytic Activity. J. Virol.
77: 8843-8856
[Abstract]
[Full Text]
-
Briggs, J. A. G., Wilk, T., Fuller, S. D.
(2003). Do lipid rafts mediate virus assembly and pseudotyping?. J. Gen. Virol.
84: 757-768
[Abstract]
[Full Text]
-
Ezelle, H. J., Markovic, D., Barber, G. N.
(2002). Generation of Hepatitis C Virus-Like Particles by Use of a Recombinant Vesicular Stomatitis Virus Vector. J. Virol.
76: 12325-12334
[Abstract]
[Full Text]
-
Chen, M., Hu, K.-F., Rozell, B., Orvell, C., Morein, B., Liljestrom, P.
(2002). Vaccination with Recombinant Alphavirus or Immune-Stimulating Complex Antigen Against Respiratory Syncytial Virus. J. Immunol.
169: 3208-3216
[Abstract]
[Full Text]